{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:08:03Z","timestamp":1789708083984,"version":"4.0.1"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"RNTP of India"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Drug-resistant TB is a serious public health problem in India. Pre-existing resistance to fluoroquinolones (FQs) and second-line injectable drugs (SLIDs) in strains of Mycobacterium tuberculosis (MTB) resistant to rifampicin (RIF) and\/or isoniazid (INH) contributes to treatment failures and consequent transmission of drug-resistant TB. A baseline assessment of resistance of MTB to FQs and SLIDs may help guide policies to further improve management of drug-resistant TB in India. This study aims to determine the prevalence of resistance to FQs and SLIDs among MTB strains having RIF and\/or INH resistance in central India.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>A total of 1032 smear positive sputum samples were subjected to line probe assay (GenoType MTBDRsl version 2) to test for resistance to FQs and SLIDs, according to the integrated diagnostic algorithm of the revised national TB control programme.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 1032 samples, 92 (8.91%) were not interpretable and hence excluded, 295 (31.38%) were resistant to FQs alone, 13 (1.38%) were resistant to SLIDs alone, 15 (1.59%) were resistant to both FQs as well as SLIDs and 617 (65.63%) were sensitive to both FQs and SLIDs. The most common mutations in gyrA and gyrB genes were observed at codons D94G and E540V, respectively. Mutations at codon A1401G in rrs genes and in the C-14\u00a0T region of eis genes were most frequently observed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>High levels of FQ resistance points towards indiscriminate use of this class of drugs. Regulation for judicial use of FQs is an urgent requirement.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/trstmh\/trz121","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T12:19:41Z","timestamp":1580386781000},"page":"249-254","source":"Crossref","is-referenced-by-count":6,"title":["Burden of baseline resistance of Mycobacterium tuberculosis to fluoroquinolones and second-line injectables in central India"],"prefix":"10.1093","volume":"114","author":[{"given":"Prabha","family":"Desikan","sequence":"first","affiliation":[{"name":"National Reference laboratory, Department of Microbiology, Bhopal Memorial Hospital, and Research Centre, Bhopal M.P. 462038, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Panwalkar","sequence":"first","affiliation":[{"name":"National Reference laboratory, Department of Microbiology, Bhopal Memorial Hospital, and Research Centre, Bhopal M.P. 462038, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Chaudhuri","sequence":"first","affiliation":[{"name":"National Reference laboratory, Department of Microbiology, Bhopal Memorial Hospital, and Research Centre, Bhopal M.P. 462038, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeba","family":"Khan","sequence":"first","affiliation":[{"name":"National Reference laboratory, Department of Microbiology, Bhopal Memorial Hospital, and Research Centre, Bhopal M.P. 462038, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram Prakash","family":"Punde","sequence":"first","affiliation":[{"name":"National Reference laboratory, Department of Microbiology, Bhopal Memorial Hospital, and Research Centre, Bhopal M.P. 462038, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Pauranik","sequence":"first","affiliation":[{"name":"National Reference laboratory, Department of Microbiology, Bhopal Memorial Hospital, and Research Centre, Bhopal M.P. 462038, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaina Beg","family":"Mirza","sequence":"first","affiliation":[{"name":"National Reference laboratory, Department of Microbiology, Bhopal Memorial Hospital, and Research Centre, Bhopal M.P. 462038, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Ranjan","sequence":"first","affiliation":[{"name":"National Reference laboratory, Department of Microbiology, Bhopal Memorial Hospital, and Research Centre, Bhopal M.P. 462038, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar","family":"Anand","sequence":"first","affiliation":[{"name":"World Health Organization, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K S","family":"Sachdeva","sequence":"first","affiliation":[{"name":"Central Tuberculosis Division, Ministry of Health and Family Welfare, New Delhi-110011, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,1,31]]},"reference":[{"issue":"9","key":"2020040802552074300_ref1","doi-asserted-by":"crossref","first-page":"a017863","DOI":"10.1101\/cshperspect.a017863","article-title":"Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis","volume":"5","author":"Seung","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2020040802552074300_ref2","author":"WHO","year":"2018"},{"key":"2020040802552074300_ref3","author":"WHO","year":"2016"},{"key":"2020040802552074300_ref4","author":"Revised National TB Control Programme"},{"key":"2020040802552074300_ref5","author":"Guidelines for PMDT in India"},{"key":"2020040802552074300_ref6","author":"Line probe assays for drug-resistant tuberculosis detection-Interpretation and reporting guide for laboratory staff and clinicians, Global Laboratory Initiative-Advancing TB Diagnosis"},{"issue":"2","key":"2020040802552074300_ref7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.idc.2016.02.010","article-title":"Drug-resistant tuberculosis. Challenges and Progress","volume":"30","author":"Kurz","year":"2016","journal-title":"Infect Dis Clin North Am."},{"issue":"3","key":"2020040802552074300_ref8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1128\/JCM.02775-15","article-title":"Gyrase mutations are associated with variable levels of Fluoroquinolone resistance in mycobacterium tuberculosis","volume":"54","author":"Farhat","year":"2016","journal-title":"J Clin Microbiol."},{"issue":"3","key":"2020040802552074300_ref9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jmii.2015.04.003","article-title":"Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant mycobacterium tuberculosis clinical isolates","volume":"49","author":"Baku\u0142a","year":"2016","journal-title":"J Microbiol Immunol Infect."},{"issue":"3","key":"2020040802552074300_ref10","doi-asserted-by":"crossref","first-page":"e0120470","DOI":"10.1371\/journal.pone.0120470","article-title":"Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical mycobacterium tuberculosis isolates: a systematic review","volume":"10","author":"Avalos","year":"2015","journal-title":"PLoS One."},{"key":"2020040802552074300_ref11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fcimb.2018.00114","article-title":"Molecular targets related drug resistance mechanisms in MDR-, XDR-, and TDR-mycobacterium tuberculosis strains","volume":"8","author":"Hameed","year":"2018","journal-title":"Front Cell Infect Microbiol."},{"key":"2020040802552074300_ref12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.diagmicrobio.2013.06.031","article-title":"Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China","volume":"77","author":"Du","year":"2013","journal-title":"Diagn Microbiol Infect Dis."},{"key":"2020040802552074300_ref13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1471-2180-14-165","article-title":"Molecular characterization of amikacin, kanamycin and capreomycin resistance in M\/XDR-TB strains isolated in Thailand","volume":"14","author":"Sowajassatakul","year":"2014","journal-title":"BMC Microbiol."},{"key":"2020040802552074300_ref14","author":"Ministry of Health and Family Welfare GoI","year":"2018"},{"issue":"6","key":"2020040802552074300_ref15","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01633-2017","article-title":"Fluoroquinolone resistance in multidrug-resistant mycobacterium tuberculosis independent of fluoroquinolone use","volume":"50","author":"Che","year":"2017","journal-title":"Eur Respir J."},{"issue":"1","key":"2020040802552074300_ref16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s13104-017-2633-6","article-title":"Emergence of fluoroquinolone resistance among drug resistant tuberculosis patients at a tertiary care facility in Karachi, Pakistan","volume":"10","author":"Zaidi","year":"2017","journal-title":"BMC Res Notes."},{"key":"2020040802552074300_ref17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4103\/0970-2113.142101","article-title":"Multidrug-resistant-tuberculosis treatment in the Indian private sector: results from a tertiary referral private hospital in Mumbai","volume":"31","author":"Udwadia","year":"2014","journal-title":"Lung India"},{"issue":"Suppl 58","key":"2020040802552074300_ref18","first-page":"P2617","article-title":"Prevalence of fluoroquinolone resistance in mycobacterium tuberculosis in a tertiary care hospital in India","volume":"44","author":"Kale","year":"2014","journal-title":"Eur Respir J."},{"issue":"2","key":"2020040802552074300_ref19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5365\/wpsar.2016.7.2.002","article-title":"Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011","volume":"7","author":"Nguyen","year":"2016","journal-title":"Western Pac Surveill Response J."},{"issue":"4","key":"2020040802552074300_ref20","first-page":"392","article-title":"Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study","volume":"130","author":"Sharma","year":"2009","journal-title":"Indian J Med Res."},{"issue":"3","key":"2020040802552074300_ref21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4103\/0971-5916.182625","article-title":"A study on pre-XDR & XDR tuberculosis and their prevalent genotypes in clinical isolates of mycobacterium tuberculosis in North India","volume":"143","author":"Singhal","year":"2016","journal-title":"Indian J Med Res."},{"key":"2020040802552074300_ref22","doi-asserted-by":"crossref","first-page":"639","DOI":"10.5455\/ijmsph.2015.19012015130","article-title":"Second-line drug resistance patterns among patients with multidrug-resistant tuberculosis of Gujarat, western India","volume":"4","author":"Patel","year":"2015","journal-title":"Int J Med Sci Pub Health."},{"issue":"4","key":"2020040802552074300_ref23","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1128\/AAC.01049-15","article-title":"Mutations in gyrA and gyrB among fluoroquinolone- and multidrug-resistant mycobacterium tuberculosis isolates","volume":"60","author":"Chien","year":"2016","journal-title":"Antimicrob Agents Chemother."},{"key":"2020040802552074300_ref24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1099\/jmm.0.046821-0","article-title":"Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin","volume":"62","author":"Nosova","year":"2013","journal-title":"J Med Microbiol."},{"issue":"1","key":"2020040802552074300_ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijmyco.2015.09.001","article-title":"Correlating rrs and eis promoter mutations in clinical isolates of mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables","volume":"5","author":"Kambli","year":"2015","journal-title":"Int J Mycobacteriol."},{"issue":"9","key":"2020040802552074300_ref26","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/jac\/dks178","article-title":"The role of eis mutations in the development of kanamycin resistance in mycobacterium tuberculosis isolates from the Moscow region","volume":"67","author":"Gikalo","year":"2012","journal-title":"J Antimicrob Chemother."},{"key":"2020040802552074300_ref27","first-page":"53","article-title":"Molecular biology of drug resistance in mycobacterium tuberculosis","volume":"374","author":"Smith","year":"2013","journal-title":"Curr Top Microbiol Immunol."},{"key":"2020040802552074300_ref28","author":"Central TB Division"}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/trstmh\/article-pdf\/114\/4\/249\/33012910\/trz121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/trstmh\/article-pdf\/114\/4\/249\/33012910\/trz121.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T06:55:37Z","timestamp":1586328937000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article\/114\/4\/249\/5687152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,31]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,1,31]]},"published-print":{"date-parts":[[2020,4,8]]}},"URL":"https:\/\/doi.org\/10.1093\/trstmh\/trz121","relation":{},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"value":"0035-9203","type":"print"},{"value":"1878-3503","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4]]},"published":{"date-parts":[[2020,1,31]]}}}